• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子受体4(ErbB-4)的s80细胞内结构域是一种组成型激活的酪氨酸激酶。

The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase.

作者信息

Linggi B, Cheng Q C, Rao A R, Carpenter G

机构信息

Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN 37232-0146, USA.

出版信息

Oncogene. 2006 Jan 5;25(1):160-3. doi: 10.1038/sj.onc.1209003.

DOI:10.1038/sj.onc.1209003
PMID:16170367
Abstract

The ErbB-4 receptor tyrosine kinase homo- and heterodimerizes following heregulin binding, which provokes increased levels of tyrosine autophosphorylation. Unique to the ErbB family, ErbB-4 is then proteolytically cleaved by alpha- and gamma-secretase to produce an 80 kDa intracellular domain (s80 ICD) fragment. This fragment is found in both the cytoplasm and nucleus of many normal and cancer cells and can interact with transcription factors in the cytoplasm and nucleus. Since the s80 ICD lacks ectodomain sequences known to play a major role in dimerization of ErbB family members, we asked whether the s80 ICD is an active tyrosine kinase. Here, we demonstrate that the s80 ICD is a constitutively active tyrosine kinase and can form homodimers. The s80 ICD is autophosphorylated in cells and can phosphorylate an exogenous substrate in vitro. Also, the s80 ICD can coassociate and dimers are detected by chemical crosslinking. This is the first example of constitutive kinase activation and dimerization totally within the cytoplasmic domain of an ErbB receptor and suggests that the s80 ICD may function to phosphorylate substrates in the cytoplasm or nucleus.

摘要

在这里,表皮生长因子(HRG)结合后,ErbB-4受体酪氨酸激酶会发生同源和异源二聚化,这会导致酪氨酸自身磷酸化水平升高。ErbB-4是ErbB家族特有的,随后会被α-和γ-分泌酶进行蛋白水解切割,产生一个80 kDa的细胞内结构域(s80 ICD)片段。在许多正常细胞和癌细胞的细胞质和细胞核中都能发现这个片段,并且它可以与细胞质和细胞核中的转录因子相互作用。由于s80 ICD缺乏已知在ErbB家族成员二聚化中起主要作用的胞外结构域序列,我们不禁要问s80 ICD是否是一种活性酪氨酸激酶。在这里,我们证明s80 ICD是一种组成型活性酪氨酸激酶,并且可以形成同源二聚体。s80 ICD在细胞中会发生自身磷酸化,并且在体外可以磷酸化外源性底物。此外,s80 ICD可以共同结合,并且通过化学交联检测到二聚体。这是ErbB受体细胞质结构域内完全组成型激酶激活和二聚化的首个例子,表明s80 ICD可能在细胞质或细胞核中磷酸化底物发挥作用。

相似文献

1
The ErbB-4 s80 intracellular domain is a constitutively active tyrosine kinase.表皮生长因子受体4(ErbB-4)的s80细胞内结构域是一种组成型激活的酪氨酸激酶。
Oncogene. 2006 Jan 5;25(1):160-3. doi: 10.1038/sj.onc.1209003.
2
HER4 D-box sequences regulate mitotic progression and degradation of the nuclear HER4 cleavage product s80HER4.HER4的D盒序列调节有丝分裂进程以及细胞核HER4裂解产物s80HER4的降解。
Cancer Res. 2007 Jul 15;67(14):6582-90. doi: 10.1158/0008-5472.CAN-06-4145.
3
gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase.γ-分泌酶对表皮生长因子受体4(ErbB-4)受体酪氨酸激酶的切割及核定位
Science. 2001 Dec 7;294(5549):2179-81. doi: 10.1126/science.1065412. Epub 2001 Oct 25.
4
The ErbB/HER receptor protein-tyrosine kinases and cancer.表皮生长因子受体(ErbB/HER)蛋白酪氨酸激酶与癌症
Biochem Biophys Res Commun. 2004 Jun 18;319(1):1-11. doi: 10.1016/j.bbrc.2004.04.150.
5
ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional repression.ErbB-4 s80细胞内结构域可消除ETO2依赖性转录抑制。
J Biol Chem. 2006 Sep 1;281(35):25373-80. doi: 10.1074/jbc.M603998200. Epub 2006 Jun 30.
6
Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment.ErbB-4细胞内结构域片段介导的Mdm2的分泌酶依赖性酪氨酸磷酸化
J Biol Chem. 2005 Sep 2;280(35):30783-7. doi: 10.1074/jbc.M506057200. Epub 2005 Jun 27.
7
Epidermal growth factor receptor juxtamembrane region regulates allosteric tyrosine kinase activation.表皮生长因子受体近膜区调节变构酪氨酸激酶激活。
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19238-43. doi: 10.1073/pnas.0703854104. Epub 2007 Nov 27.
8
The HER4 cytoplasmic domain, but not its C terminus, inhibits mammary cell proliferation.HER4的胞质结构域而非其C末端可抑制乳腺细胞增殖。
Mol Endocrinol. 2007 Aug;21(8):1861-76. doi: 10.1210/me.2006-0101. Epub 2007 May 15.
9
The intracellular domain of ErbB4 induces differentiation of mammary epithelial cells.ErbB4的细胞内结构域可诱导乳腺上皮细胞分化。
Mol Biol Cell. 2006 Sep;17(9):4118-29. doi: 10.1091/mbc.e06-02-0101. Epub 2006 Jul 12.
10
An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.一种用于表皮生长因子受体(EGFR/ErbB)家族自抑制和激活的静电引擎模型。
J Gen Physiol. 2005 Jul;126(1):41-53. doi: 10.1085/jgp.200509274. Epub 2005 Jun 13.

引用本文的文献

1
An Unbiased Functional Genetics Screen Identifies Rare Activating ERBB4 Mutations.一项无偏功能性遗传学筛选鉴定出罕见的激活型 ERBB4 突变。
Cancer Res Commun. 2022 Jan 7;2(1):10-27. doi: 10.1158/2767-9764.CRC-21-0021. eCollection 2022 Jan.
2
The Yin and Yang of ERBB4: Tumor Suppressor and Oncoprotein.ERBB4 的阴阳两面:肿瘤抑制蛋白和癌蛋白。
Pharmacol Rev. 2022 Jan;74(1):18-47. doi: 10.1124/pharmrev.121.000381.
3
Canonical ErbB-2 isoform and ErbB-2 variant c located in the nucleus drive triple negative breast cancer growth.
经典型 ErbB-2 异构体和位于核内的 ErbB-2 变体 c 驱动三阴性乳腺癌生长。
Oncogene. 2020 Sep;39(39):6245-6262. doi: 10.1038/s41388-020-01430-9. Epub 2020 Aug 25.
4
Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics.肝细胞癌中 Axl 受体脱落的动力学及其治疗学意义。
Int J Mol Sci. 2018 Dec 18;19(12):4111. doi: 10.3390/ijms19124111.
5
Advanced development of ErbB family-targeted therapies in osteosarcoma treatment.在骨肉瘤治疗中,针对 ErbB 家族的靶向治疗的深入发展。
Invest New Drugs. 2019 Feb;37(1):175-183. doi: 10.1007/s10637-018-0684-8. Epub 2018 Oct 24.
6
SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase.小泛素样修饰(SUMOylation)调节ErbB4受体酪氨酸激酶可溶性细胞内结构域的核积累和信号活性。
J Biol Chem. 2017 Dec 1;292(48):19890-19904. doi: 10.1074/jbc.M117.794271. Epub 2017 Oct 3.
7
Neuregulin 1 improves complex 2-mediated mitochondrial respiration in skeletal muscle of healthy and diabetic mice.神经调节蛋白 1 可改善健康和糖尿病小鼠骨骼肌中介导的线粒体呼吸复合物 2。
Sci Rep. 2017 May 11;7(1):1742. doi: 10.1038/s41598-017-02029-z.
8
Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis.ERBB4 JM-a CYT-1和CYT-2亚型在转基因小鼠中的过表达揭示了其在乳腺发育和致癌作用中的亚型特异性作用。
Breast Cancer Res. 2014 Dec 17;16(6):501. doi: 10.1186/s13058-014-0501-z.
9
The interaction of the ErbB4 intracellular domain p80 with α-enolase in the nuclei is associated with the inhibition of the neuregulin1-dependent cell proliferation.细胞核中表皮生长因子受体4(ErbB4)细胞内结构域p80与α-烯醇化酶的相互作用与抑制神经调节蛋白1依赖的细胞增殖有关。
Int J Biochem Mol Biol. 2014 May 15;5(1):21-9. eCollection 2014.
10
Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells.乳腺上皮细胞中ErbB4亚型的趋同和趋异细胞反应。
Mol Cancer Res. 2014 Aug;12(8):1140-55. doi: 10.1158/1541-7786.MCR-13-0637. Epub 2014 May 14.